PCAS

Longjumeau, France Founded: 1962 • Age: 64 yrs Listed
Manufacturer of complex molecules for Lifesciences industry

About PCAS

PCAS is a publicly listed company based in Longjumeau (France) founded in 1962. Manufacturer of complex molecules for Lifesciences industry. Its chief executive, as recorded, is Frederic Desdouits. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production.

Company details

PCAS Group was founded in 1962 and is headquartered in Longjumeau, France. Processes are developed and complex molecules are produced for life sciences and specialty chemicals sectors. Expertise is held in API and intermediates manufacturing, as well as drug delivery systems and excipients. Operations focus on custom synthesis and industrial-scale production to support pharmaceutical and related applications.

  • Headquarters Longjumeau, France
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website pcas.com
  • Social LinkedIn
Key Metrics

Funding Insights of PCAS

  • Total Rounds 4
  • Last Round Grant β€” $2.5M
  • Investors Count 3

All 4 funding rounds of PCAS with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2024$2.5MGrant––
May 2020$349,521Grant––
Feb 2015$1.12MGrant––
Oct 2014Debt – Conventional––
Valuation history

3 investors in total: 3 institutional.

Investors in PCAS

PCAS has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Tikehau Capital, European Union and Ministry of Economy, Finance and Industrial and Digital Sovereignty.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Debt and equity investments are managed by the private fund.
2013tikehaucapital.comLondon, United Kingdom
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
economie.gouv.fr
Premium access

Investor details for PCAS

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of PCAS

10 people are tracked at PCAS (3 in leadership, 7 in board & advisors).

NameRoleGroup
Frederic Desdouits
Ex-CEOLeadership
Vincent Touraille
CEOLeadership
Jean-Louis Martin
Acting Chief Executive OfficerLeadership
Vincent Milhau
DirectorBoard & advisors
Pierre Luzeau
ChairmanBoard & advisors
Marc De Rocquefeuil
DirectorBoard & advisors
Pauline De Robert Hautequere
DirectorBoard & advisors
Jacqueline Lecourtier
DirectorBoard & advisors
Vanessa Michoud
DirectorBoard & advisors
Alain De Salaberry
DirectorBoard & advisors
Premium access

Complete people profiles for PCAS

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of PCAS

3 dated milestones of PCAS across 62 years, from founding to its latest funding, stage changes and deals.

  1. Founded PCAS is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant, of $2.5M.

Web traffic of PCAS

Websites that share an audience with PCAS (pcas.com).

Similar websites

Websites whose visitors overlap most with PCAS. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ischem.com
ischem.com
100%
–
phtchemical.com
phtchemical.com
100%
–
mid-chem.com
mid-chem.com
100%
–
parchem.com
81%
View details
mcgean.com
mcgean.com
62%
#6,935,984–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Pcas

Premium access

Complete news archive for PCAS

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about PCAS

PCAS was founded in 1962 and raised its 1st funding round 52 years after it was founded.

PCAS is headquartered in Longjumeau, France. It is registered at Longjumeau, Ile-de-france, France.

Frederic Desdouits is the CEO of PCAS, as recorded in our data.

PCAS Group was founded in 1962 and is headquartered in Longjumeau, France. Processes are developed and complex molecules are produced for life sciences and specialty chemicals sectors. Expertise is held in API and intermediates manufacturing, as well as drug delivery systems and excipients. Operations focus on custom synthesis and industrial-scale production to support pharmaceutical and related applications.

PCAS has 3 investors. Key investors include Tikehau Capital, European Union, and Ministry of Economy, Finance and Industrial and Digital Sovereignty.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available